A Post Marketing Surveillance Study Assessing the Long-term Efficacy and Safety of Aptivus Co-administered With Low-dose Ritonavir in Treatment Experienced Patients With HIV-1 Infection in the Daily Clinical Practice.
Clinical trial NCT00976950 · COMPLETED
Trial details
- NCT number
- NCT00976950
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2009-09-01
- Primary completion
- 2011-07-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.